dr. o’malley on the activity of mirvetuximab soravtansine in ovarian cancer
Published 4 years ago • 595 plays • Length 1:13Download video MP4
Download video MP3
Similar videos
-
1:15
dr. o’malley on the safety profile of mirvetuximab in ovarian cancer
-
0:58
dr. o’malley on the utility of mirvetuximab in ovarian cancer
-
1:47
dr. o’malley on antitumor activity with veliparib combo in serous ovarian cancer
-
2:28
dr. moore on the role of mirvetuximab soravtansine in ovarian cancer
-
1:08
dr. o’malley on the state of immunotherapy in ovarian cancer
-
1:49
dr. moore on safety profile of mirvetuximab soravtansine in ovarian cancer
-
1:09
dr. o’malley on research with immunotherapy in ovarian cancer
-
1:15
dr. o’malley on remaining questions in ovarian cancer
-
4:53
sean o'malley vs merab dvalishvili full fight ufc 306
-
2:39
who's next for sean o'malley after title loss to merab dvalishvili? | ufc 306 matchmaker
-
2:56
elahere injection how to use: uses, dosage, side effects, contraindications
-
1:35
dr. o’malley on ongoing clinical trials evaluating immunotherapy in ovarian cancer
-
1:59
dr. gilbert on the safety profile of mirvetuximab soravtansine/bevacizumab in ovarian cancer
-
2:15
dr. moore on early-phase data with mirvetuximab soravtansine in ovarian cancer
-
1:18
dr. o'malley on the tolerability of parp inhibitors in ovarian cancer
-
1:10
dr. o'malley on fda approval of maintenance rucaparib in ovarian cancer
-
1:59
dr. english on mirvetuximab soravtansine in ovarian cancer
-
7:40
i/o combination strategies in ovarian cancer
-
1:47
mirvetuximab soravtansine remains well tolerated in platinum-resistant ovarian cancer
-
1:41
dr. moore on benefit of mirvetuximab soravtansine in patients with ovarian cancer
-
1:27
dr. gilbert on evaluating mirvetuximab soravtansine in platinum-agnostic ovarian cancer
-
2:09
dr. comerci on the utility of primary debulking surgery in ovarian cancer